140 related articles for article (PubMed ID: 36137195)
21. Neuroendocrine Carcinoma as a Cause of Humoral Hypercalcemia of Malignancy: A Case of a Patient With Elevated Parathyroid Hormone-Related Protein.
Christensen BR; Rendo MJ; Beeler BW; Huddleston BJ; Fenderson JL
Cureus; 2022 Mar; 14(3):e23398. PubMed ID: 35481321
[TBL] [Abstract][Full Text] [Related]
22. A case of acute lymphoblastic leukemia accompanied with the production of parathyroid hormone-related protein.
Harutsumi M; Akazai A; Kitamura T; Manki A; Tanaka H; Oda M; Seino Y
Miner Electrolyte Metab; 1995; 21(1-3):171-6. PubMed ID: 7565443
[TBL] [Abstract][Full Text] [Related]
23. Denosumab is Effective for Controlling Serum Calcium Levels in Patients with Humoral Hypercalcemia of Malignancy Syndrome: A Case Report on Parathyroid Hormone-related Protein-producing Cholangiocarcinoma.
Ashihara N; Nakajima K; Nakamura Y; Kobayashi M; Shirahata K; Maeda C; Uehara T; Gomi D; Ito N
Intern Med; 2016; 55(23):3453-3457. PubMed ID: 27904108
[TBL] [Abstract][Full Text] [Related]
24. Treatment of malignancy-associated hypercalcemia and cachexia with humanized anti-parathyroid hormone-related protein antibody.
Sato K; Onuma E; Yocum RC; Ogata E
Semin Oncol; 2003 Oct; 30(5 Suppl 16):167-73. PubMed ID: 14613038
[TBL] [Abstract][Full Text] [Related]
25. Raised plasma concentrations of parathyroid hormone related peptide in hypercalcemic multiple myeloma.
Horiuchi T; Miyachi T; Arai T; Nakamura T; Mori M; Ito H
Horm Metab Res; 1997 Sep; 29(9):469-71. PubMed ID: 9370119
[TBL] [Abstract][Full Text] [Related]
26. Effects of treatment of malignancy-associated hypercalcemia on serum parathyroid hormone-related protein.
Budayr AA; Zysset E; Jenzer A; Thiébaud D; Ammann P; Rizzoli R; Jaquet-Müller F; Bonjour JP; Gertz B; Burckhardt P
J Bone Miner Res; 1994 Apr; 9(4):521-6. PubMed ID: 8030440
[TBL] [Abstract][Full Text] [Related]
27. Development of a sensitive two-site immunoradiometric assay for parathyroid hormone-related peptide: evidence for elevated levels in plasma from patients with adult T-cell leukemia/lymphoma and B-cell lymphoma.
Ikeda K; Ohno H; Hane M; Yokoi H; Okada M; Honma T; Yamada A; Tatsumi Y; Tanaka T; Saitoh T
J Clin Endocrinol Metab; 1994 Nov; 79(5):1322-7. PubMed ID: 7962324
[TBL] [Abstract][Full Text] [Related]
28. Transcription of the gene for parathyroid hormone-related peptide from the human is activated through a cAMP-dependent pathway by prostaglandin E1 in HTLV-I-infected T cells.
Ikeda K; Okazaki R; Inoue D; Ogata E; Matsumoto T
J Biol Chem; 1993 Jan; 268(2):1174-9. PubMed ID: 8380405
[TBL] [Abstract][Full Text] [Related]
29. Hypercalcemia, parathyroid hormone-related protein expression and human T-cell leukemia virus infection.
Prager D; Rosenblatt JD; Ejima E
Leuk Lymphoma; 1994 Aug; 14(5-6):395-400. PubMed ID: 7812198
[TBL] [Abstract][Full Text] [Related]
30. Cell-type-specific transactivation of the parathyroid hormone-related protein gene promoter by the human T-cell leukemia virus type I (HTLV-I) tax and HTLV-II tax proteins.
Ejima E; Rosenblatt JD; Massari M; Quan E; Stephens D; Rosen CA; Prager D
Blood; 1993 Feb; 81(4):1017-24. PubMed ID: 8427983
[TBL] [Abstract][Full Text] [Related]
31. Parathyroid hormone-related protein: elevated levels in both humoral hypercalcemia of malignancy and hypercalcemia complicating metastatic breast cancer.
Grill V; Ho P; Body JJ; Johanson N; Lee SC; Kukreja SC; Moseley JM; Martin TJ
J Clin Endocrinol Metab; 1991 Dec; 73(6):1309-15. PubMed ID: 1955513
[TBL] [Abstract][Full Text] [Related]
32. A novel bioluminescent mouse model and effective therapy for adult T-cell leukemia/lymphoma.
Shu ST; Nadella MV; Dirksen WP; Fernandez SA; Thudi NK; Werbeck JL; Lairmore MD; Rosol TJ
Cancer Res; 2007 Dec; 67(24):11859-66. PubMed ID: 18089816
[TBL] [Abstract][Full Text] [Related]
33. Mechanism of hypercalcemia in adult T-cell leukemia: overexpression of receptor activator of nuclear factor kappaB ligand on adult T-cell leukemia cells.
Nosaka K; Miyamoto T; Sakai T; Mitsuya H; Suda T; Matsuoka M
Blood; 2002 Jan; 99(2):634-40. PubMed ID: 11781248
[TBL] [Abstract][Full Text] [Related]
34. Tumor necrosis factor enhances parathyroid hormone-related protein-induced hypercalcemia and bone resorption without inhibiting bone formation in vivo.
Uy HL; Mundy GR; Boyce BF; Story BM; Dunstan CR; Yin JJ; Roodman GD; Guise TA
Cancer Res; 1997 Aug; 57(15):3194-9. PubMed ID: 9242449
[TBL] [Abstract][Full Text] [Related]
35. [Changes in mineral metabolism in stage 3, 4, and 5 chronic kidney disease (not on dialysis)].
Lorenzo Sellares V; Torregrosa V
Nefrologia; 2008; 28 Suppl 3():67-78. PubMed ID: 19018742
[TBL] [Abstract][Full Text] [Related]
36. Conflicting actions of parathyroid hormone-related protein and serum calcium as regulators of 25-hydroxyvitamin D(3)-1 alpha-hydroxylase expression in a nude rat model of humoral hypercalcemia of malignancy.
Michigami T; Yamato H; Suzuki H; Nagai-Itagaki Y; Sato K; Ozono K
J Endocrinol; 2001 Nov; 171(2):249-57. PubMed ID: 11691644
[TBL] [Abstract][Full Text] [Related]
37. The inhibition of RANKL causes greater suppression of bone resorption and hypercalcemia compared with bisphosphonates in two models of humoral hypercalcemia of malignancy.
Morony S; Warmington K; Adamu S; Asuncion F; Geng Z; Grisanti M; Tan HL; Capparelli C; Starnes C; Weimann B; Dunstan CR; Kostenuik PJ
Endocrinology; 2005 Aug; 146(8):3235-43. PubMed ID: 15845617
[TBL] [Abstract][Full Text] [Related]
38. Humoral hypercalcemia of malignancy in a patient with large cell carcinoma of the lung: report of case and review of literature.
Makdissi A; Zimmerman RS
Endocr Pract; 2007; 13(4):389-95. PubMed ID: 17669716
[TBL] [Abstract][Full Text] [Related]
39. PTHrP-independent hypercalcemia with increased proinflammatory cytokines and bone resorption in two children with CD19-negative precursor B acute lymphoblastic leukemia.
Niizuma H; Fujii K; Sato A; Fujiwara I; Takeyama J; Imaizumi M
Pediatr Blood Cancer; 2007 Dec; 49(7):990-3. PubMed ID: 16496289
[TBL] [Abstract][Full Text] [Related]
40. Hypercalcemia of malignancy and new treatment options.
Sternlicht H; Glezerman IG
Ther Clin Risk Manag; 2015; 11():1779-88. PubMed ID: 26675713
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
